Pharmacists Emerge as Key Educators in Women's Health, Destigmatizing Menstrual Pain
Explore effective strategies for managing menstrual pain, including diet, exercise, and nonpharmacological therapies, while embracing women's health awareness.
Pharmacist Discusses Top OTC Strategies for Managing Menstrual Pain
Joanna Lewis, PharmD, MBA explores effective over-the-counter solutions for menstrual cramps, including NSAIDs, supplements, and tips for optimal relief.
Patients Must Seek Pharmacists, Other Providers For Reproductive Health as Abortion Clinics Close
Abortion clinic closures impact reproductive health access, prompting a shift towards pharmacists for contraceptive care and highlighting urgent public health needs.
Pharmacy Industry Leaders Gather to Discuss Most Favored Nation Drug Policy
The panel discussion features pharmacy leaders, policy experts, and well-known legal minds discussing the Most Favored Nation drug policy and its overarching implications.
What New ICU Guidelines Mean for the Pharmacist Profession
While the new guidelines are reserved for critical care pharmacists in the ICU, they can be applied to other practice areas, highlighting the crucial role pharmacists play in health care.
Suboptimal Pneumococcal, Flu Vaccine Rates Persist Among People with HIV
Due to an increased risk of vaccine-preventable diseases, researchers explore pneumococcal, COVID-19, and influenza vaccine coverage among people living with HIV in Belgium.
FDA Issues New Guidance to Accelerate Development of Safe, Effective Nonopioid Pain Treatments
As part of the guidance, the FDA emphasizes drug development, specifically with trial design, patient populations, and outcomes such as reducing the need for opioids.
HHS and American Academy of Pediatrics Differ on COVID-19 Vaccine Recommendation
As the 2025-2026 respiratory season approaches, the CDC’s Advisory Committee on Immunization Practices has not met and voted on guidelines for COVID-19 vaccines.
Integration of Health Care Technology Is Feasible in Independent Pharmacy Setting
Researchers conduct a proof-of-concept study exploring the feasibility of health information technology interoperability between a medical office and independent pharmacies.
Q&A: How Pharmacists Are Being Formalized as Essential Clinical Partners
Andrea Sikora, PharmD, MSCR, FCCM, FCCP, BCCCP, led a 21-member panel on critical care pharmacists and joined us to discuss how guideline updates may impact the greater pharmacy industry.
Digital Clinical Decision Support Improves Treatment for Patients With Obesity
In hospitalized patients with obesity, researchers conduct a study detailing how electronic clinical support helps participants optimize their treatment regimens.
NCPA: More Than 125 Groups Urge Congress to Pass PBM Reform
Along with additional bills to further bolster PBM reform, the organizations are aiming to pass the PBM Reform Act for improved medication costs and community pharmacy sustainability.
Q&A: New ICU Guidelines Highlight, Confirm Role of Critical Care Pharmacists
Andrea Sikora, PharmD, MSCR, FCCM, FCCP, BCCCP, chair of the committee presenting new guidelines, discussed her role in bolstering pharmacists’ support in the ICU.
Diabetes Care Is Significantly Lacking for People With HIV
Among individuals with both diabetes and HIV, researchers determine patients’ adherence to comprehensive diabetes care interventions.
Pharmacy Owners Say They Are Unable to Participate in MDPNP
The Medicare Drug Price Negotiation Program is anticipated to cause multiple issues for pharmacy owners and their cashflow sustainability.
Olezarsen Demonstrates Favorable Reductions in Triglycerides for Hypertriglyceridemia
Olezarsen significantly reduces triglycerides and acute pancreatitis events, offering new hope for patients with severe hypertriglyceridemia.
FDA Approves Medtronic’s MiniMed System for Type 2 Diabetes
Medtronic’s diabetes management technology reached 2 milestones upon FDA approval, allowing integration of continuous glucose monitoring for patients with type 1 and type 2 diabetes.
How Real Patient Experiences Have Helped Bolster Advocacy for PBM Reform
After experiencing tragedy in his personal life, Bil Schmidtknecht was led to join the community of independent pharmacists and industry advocates calling for PBM reform across both aisles.
COVID-19 Pandemic Significantly Impacts Pneumococcal Mortality Trends
Exploring the influences of pneumococcal disease mortality and events of the COVID-19 pandemic, researchers investigate changes in US pneumococcus survival rates since 2020.
About 1 in 4 Pharmacies Dispense Buprenorphine, But Disparities Persist
In pharmacies in predominantly Black and Latino neighborhoods, only 18% and 17% were likely to carry buprenorphine compared with white neighborhoods.
Orforglipron Shows Significant Weight Loss in New Phase 3 Study
Orforglipron shows results in weight loss and diabetes management, offering a new oral treatment option for patients.
Hypertension Mortality Rose Significantly from 1999 to 2019
With hypertension commonly leading to increased risk of mortality, researchers aimed to understand the hypertensive survival rates of patients with diabetes over a 20-year period.
Achieving PBM Reform Through Public Engagement, Advocacy
Regardless of which stakeholders are involved, a collective, team effort is necessary to achieve state- and federal-level PBM reform.
CVS, Walgreens Will Limit COVID-19 Vaccine Offerings in 16 States
CVS will not offer COVID-19 vaccines in Massachusetts, Nevada, and New Mexico.
Wegovy Outperforms Tirzepatide in Reducing Major Adverse Cardiovascular Events
A real-world study found that semaglutide significantly reduced the risk of major cardiovascular events compared to tirzepatide.
Community Health Programs Improved Outcomes Among Black Patients
Using results from the Rx for Change program in Pittsburgh, Pennsylvania, researchers explored an integrative approach to cardiometabolic disease management among Black patients.
FDA Approves Biosimilars for Prolia, Xgeva
The FDA approves denosumab-nxxp (Bildyos and Bilprevda), enhancing access to vital bone health treatments for osteoporosis and cancer-related conditions.
Prescription-to-OTC Switch of Triptans Showed Positive Public Health Impact
Detailing the public health impact of an Rx-to-OTC switch, researchers explored the reclassification of triptan medications in Germany.
Q&A: Equity in Pharmacy Means Meeting Patients Where They Are
Pharmacists advance equity by personalizing care and addressing health literacy to meet patients where they are.
FDA Approves Lecanemab Subcutaneous Formulation as Maintenance Dose for Alzheimer Disease
FDA approves Leqembi's subcutaneous formulation, enhancing accessibility for Alzheimer treatment and paving the way for future combination therapies.
